ABX-196
- Generic Name
- ABX-196
- Drug Type
- Small Molecule
- Chemical Formula
- C50H98N2O9
- CAS Number
- 1161877-58-2
- Unique Ingredient Identifier
- SOI87F7GN2
- Background
ABX-196 is under investigation in clinical trial NCT03897543 (ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma).
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
- First Posted Date
- 2019-04-01
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- Abivax S.A.
- Target Recruit Count
- 48
- Registration Number
- NCT03897543
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Scripps Clinic Torrey Pines, La Jolla, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath